or
forgot password
  • cancer clinical trials in los angeles, CA

  • Strategic Timing of Antiretroviral Treatment
    VA Greater Los Angeles Healthcare System

    Trial Locations
    VA Greater Los Angeles Healthcare System
    UCLA CARE-4-Families (LABAC CRS)
    HIV Infection
    Laparoscopic Radiofrequency Ablation of Symptomatic Uterine Fibroids
    USC Medical Center
    Los Angeles, California 90033
    Uterine Fibroids, Uterine Myomas
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
    University of California at Los Angeles Dept. of UCLA
    Los Angeles, California 90095
    Breast Cancer
    Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Liver Cancer
    F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
    UCLA

    Trial Locations
    UCLA
    VA West Los Angles Medical Center
    Cedar-Sinai Medical Center
    Bone Metastases
    N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
    Children's Hospital Los Angeles
    Los Angeles, California 90027-0700
    Neuroblastoma
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cedars-Sinai Medical Center
    Los Angeles, California 90048
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
    Jonsson Comprehensive Cancer Center
    Los Angeles, California 90095
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Langerhans Cell Histiocytosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Aggressive NK-cell Leukemia, AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Malignancies, AIDS-related Small Noncleaved Cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Clear Cell Renal Cell Carcinoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, HIV Infection, HIV-associated Hodgkin Lymphoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Light Chain Deposition Disease, Mast Cell Leukemia, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Myeloid/NK-cell Acute Leukemia, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Osteolytic Lesions of Multiple Myeloma, Peripheral T-cell Lymphoma, Plasma Cell Neoplasm, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Renal Cell Cancer, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Stage IV Renal Cell Cancer, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
    University of Southern California
    Los Angeles, California 90033
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Estrogen Receptor-negative Breast Cancer, Fallopian Tube Cancer, HER2-negative Breast Cancer, Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2), Male Breast Cancer, Primary Peritoneal Cavity Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Pancreatic Cancer, Recurrent Prostate Cancer, Triple-negative Breast Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    Jonsson Comprehensive Cancer Center
    Los Angeles, California 90095
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Brain and Central Nervous System Tumors
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Cancer
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Trial Locations
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Childrens Hospital Los Angeles
    Mattel Children's Hospital at UCLA
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Mattel Children's Hospital at UCLA
    Los Angeles, California 90095
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Childrens Hospital Los Angeles

    Trial Locations
    Childrens Hospital Los Angeles
    Mattel Children's Hospital at UCLA
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Mattel Children's Hospital at UCLA
    Los Angeles, California 90095
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Lymphoma
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    University of California at Los Angeles Dept. of UCLA (3)
    Los Angeles, California 90095
    Renal Cell Carcinoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Trial Locations
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Childrens Hospital Los Angeles
    Mattel Children's Hospital at UCLA
    Neuroblastoma
    Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
    University of Southern California (USC)
    Los Angeles, California 90007
    Glioblastoma Multiforme
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    Children's Hospital Los Angeles
    David Geffen School of Medicine at UCLA
    Mattel Children's Hospital UCLA
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
    University of California Los Angeles
    Los Angeles, California 90095-6951
    Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    University of Southern California Keck School of Medicine/University of Southern California LAC & USC Medical Center
    Los Angeles, California
    Multiple Sclerosis, Relapsing-Remitting
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location# 053
    Los Angeles, California 90095
    Metastatic Colorectal Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    University of Southern California

    Trial Locations
    University of Southern California
    Jonsson Comprehensive Cancer Center
    TORI- Central Regulatory
    TORI- Central Pharmacy
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Short-Term Fasting: Impact on Toxicity
    USC/Norris Comprehenseive Cancer Center
    Los Angeles, California 90033
    Fasting in Malignant Solid Tumors
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Prostate Cancer
    Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Childhood Cancers
    Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
    Pituitary Center Cedars-Sinai Medical Center
    Los Angeles, California 90048
    Pituitary Adenomas, Prolactinomas, Cushing's Disease
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    USC/Kenneth Norris Comprehensive Cancer Center USC

    Trial Locations
    USC/Kenneth Norris Comprehensive Cancer Center USC
    University of California at Los Angeles UCLA
    Myelodysplastic Syndromes
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Children's Hospital Los Angeles
    Los Angeles, California 90027-0700
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Leukemia
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Lung Cancer